Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity
- PMID: 8189487
- PMCID: PMC236850
- DOI: 10.1128/JVI.68.6.3478-3485.1994
Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity
Abstract
The role of human immunodeficiency virus type 1 (HIV-1) accessory genes in pathogenesis has remained unclear because of the lack of a suitable in vivo model. The most controversial of these genes is nef. We investigated the requirement for Nef for in vivo replication and pathogenicity of two isolates of HIV-1 (HIV-1JR-CSF and HIV-1NL4-3) in human fetal thymus and liver implants in severe combined immunodeficient mice. HIV-1JR-CSF and HIV-1NL4-3 differ in their in vitro phenotypes in that HIV-1JR-CSF does not induce syncytia and is relatively noncytopathic, while HIV-1NL4-3 is highly cytopathic and readily induces syncytia. The nef mutants of both isolates grew with kinetics similar to those of parental virus strains in stimulated peripheral blood lymphocytes but demonstrated attenuated growth properties in vivo. HIV-1NL4-3 induced severe depletion of human thymocytes within 6 weeks of infection, whereas its nef mutant did not. Thus, HIV-1 Nef is required for efficient in vivo viral replication and pathogenicity.
Similar articles
-
Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.J Virol. 1996 Mar;70(3):1505-11. doi: 10.1128/JVI.70.3.1505-1511.1996. J Virol. 1996. PMID: 8627668 Free PMC article.
-
In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates.J Virol. 1995 Oct;69(10):6259-64. doi: 10.1128/JVI.69.10.6259-6264.1995. J Virol. 1995. PMID: 7666526 Free PMC article.
-
Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo.J Virol. 1997 Nov;71(11):8456-66. doi: 10.1128/JVI.71.11.8456-8466.1997. J Virol. 1997. PMID: 9343202 Free PMC article.
-
Modelling thymic HIV-1 Nef effects.Curr HIV Res. 2006 Jan;4(1):57-64. doi: 10.2174/157016206775197583. Curr HIV Res. 2006. PMID: 16454711 Review.
-
Immunodeficiency viruses. Not enough sans Nef.Curr Biol. 1994 Jul 1;4(7):618-20. doi: 10.1016/s0960-9822(00)00135-4. Curr Biol. 1994. PMID: 7953537 Review.
Cited by
-
Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo.J Virol. 1999 Nov;73(11):9089-97. doi: 10.1128/JVI.73.11.9089-9097.1999. J Virol. 1999. PMID: 10516015 Free PMC article.
-
Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.J Virol. 1998 Nov;72(11):8650-8. doi: 10.1128/JVI.72.11.8650-8658.1998. J Virol. 1998. PMID: 9765405 Free PMC article.
-
Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo.J Virol. 1999 May;73(5):3968-74. doi: 10.1128/JVI.73.5.3968-3974.1999. J Virol. 1999. PMID: 10196292 Free PMC article.
-
The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable.J Virol. 1997 May;71(5):3641-51. doi: 10.1128/JVI.71.5.3641-3651.1997. J Virol. 1997. PMID: 9094638 Free PMC article.
-
Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.J Virol. 2001 Dec;75(24):12081-7. doi: 10.1128/JVI.75.24.12081-12087.2001. J Virol. 2001. PMID: 11711598 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources